Doximity (NYSE:DOCS) Director Kira Scherer Wampler Sells 2,000 Shares of Stock

Doximity, Inc. (NYSE:DOCS) Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $24.95, for a total transaction of $49,900.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $494,983.05. The trade was a 9.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity Price Performance

DOCS opened at $25.60 on Friday. The company’s 50-day moving average is $22.58 and its 200 day moving average is $23.05. Doximity, Inc. has a fifty-two week low of $17.15 and a fifty-two week high of $76.51. The firm has a market capitalization of $4.56 billion, a P/E ratio of 30.12, a PEG ratio of 19.35 and a beta of 1.29.

Doximity (NYSE:DOCS) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.13. The business had revenue of $156.62 million during the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share. On average, equities research analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current year.

Analysts Set New Price Targets

DOCS has been the subject of several recent research reports. Canaccord Genuity Group set a $36.00 price objective on Doximity in a report on Friday, August 7th. Piper Sandler restated an “overweight” rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a research report on Friday, August 7th. Citigroup cut shares of Doximity to an “underperform” rating in a report on Monday, June 29th. The Goldman Sachs Group lowered their price objective on Doximity from $28.00 to $24.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Finally, JPMorgan Chase & Co. upped their target price on Doximity from $26.00 to $31.00 and gave the stock a “neutral” rating in a research note on Friday, August 7th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $32.43.

Institutional Trading of Doximity

A number of hedge funds have recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. raised its stake in shares of Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after acquiring an additional 397 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Doximity during the 3rd quarter valued at $111,000. Farther Finance Advisors LLC grew its holdings in shares of Doximity by 35.7% during the 4th quarter. Farther Finance Advisors LLC now owns 1,539 shares of the company’s stock valued at $68,000 after purchasing an additional 405 shares during the last quarter. Leonteq Securities AG purchased a new position in Doximity in the 4th quarter worth $78,000. Finally, Kestra Advisory Services LLC purchased a new position in Doximity in the 4th quarter worth $87,000. Institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.